A.R.T. Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-5,600
| Closed | -$657K | – | 1336 |
|
|
2017
Q3 | $657K | Sell |
5,600
-44,900
| -89% | -$5.27M | 0.03% | 718 |
|
|
2017
Q2 | $4.03M | Buy |
50,500
+42,300
| +516% | +$3.37M | 0.21% | 101 |
|
|
2017
Q1 | $420K | Sell |
8,200
-34,500
| -81% | -$1.77M | 0.02% | 870 |
|
|
2016
Q4 | $1.6M | Buy |
+42,700
| New | +$1.6M | 0.1% | 337 |
|
|
2016
Q3 | – | Sell |
-29,084
| Closed | -$1.61M | – | 644 |
|
|
2016
Q2 | $1.61M | Sell |
29,084
-3,900
| -12% | -$216K | 0.08% | 379 |
|
|
2016
Q1 | $2.07M | Buy |
+32,984
| New | +$2.07M | 0.09% | 322 |
|
|
2015
Q4 | – | Sell |
-10,891
| Closed | -$875K | – | 1442 |
|
|
2015
Q3 | $875K | Sell |
10,891
-10,113
| -48% | -$812K | 0.03% | 670 |
|
|
2015
Q2 | $2.52M | Sell |
21,004
-11,294
| -35% | -$1.35M | 0.08% | 367 |
|
|
2015
Q1 | $3.37M | Buy |
32,298
+21,946
| +212% | +$2.29M | 0.12% | 239 |
|
|
2014
Q4 | $1M | Buy |
+10,352
| New | +$1M | 0.04% | 643 |
|
|
2014
Q2 | – | Sell |
-11,349
| Closed | -$761K | – | 1287 |
|
|
2014
Q1 | $761K | Buy |
+11,349
| New | +$761K | 0.04% | 595 |
|
|
2013
Q4 | – | Sell |
-121,215
| Closed | -$7.76M | – | 1252 |
|
|
2013
Q3 | $7.76M | Buy |
121,215
+9,755
| +9% | +$624K | 0.42% | 20 |
|
|
2013
Q2 | $3.46M | Buy |
+111,460
| New | +$3.46M | 0.11% | 254 |
|